Ivermectin ineffective as COVID-19 preventive in small trial
Ivermectin didn't prevent COVID-19 in a small trial of exposed asymptomatic adults.
Why it matters
- Study addresses controversial Ivermectin use for COVID-19 prevention.
By the numbers
- Pilot trial with single oral low dose of Ivermectin given within 72 hours of exposure.
The big picture
- Study adds to evidence on Ivermectin's role in COVID-19.
What they're saying
- Small sample size, minimal impact noted by critics.
- Study appreciated for addressing Ivermectin controversy.
- Journal's reputation criticized; findings should be interpreted cautiously.
Caveats
- Small, pilot trial; larger studies needed.
- Journal's reputation criticized; interpret findings cautiously.
What’s next
- Further research on Ivermectin's role in COVID-19 prevention needed.